Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Results Phys ; 38: 105653, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35664991

RESUMO

Reinfection and reactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have recently raised public health pressing concerns in the fight against the current pandemic globally. In this study, we propose a new dynamic model to study the transmission of the coronavirus disease 2019 (COVID-19) pandemic. The model incorporates possible relapse, reinfection and environmental contribution to assess the combined effects on the overall transmission dynamics of SARS-CoV-2. The model's local asymptotic stability is analyzed qualitatively. We derive the formula for the basic reproduction number ( R 0 ) and final size epidemic relation, which are vital epidemiological quantities that are used to reveal disease transmission status and guide control strategies. Furthermore, the model is validated using the COVID-19 reported situations in Saudi Arabia. Moreover, sensitivity analysis is examined by implementing a partial rank correlation coefficient technique to obtain the ultimate rank model parameters to control or mitigate the pandemic effectively. Finally, we employ a standard Euler technique for numerical simulations of the model to elucidate the influence of some crucial parameters on the overall transmission dynamics. Our results highlight that contact rate, hospitalization rate, and reactivation rate are the fundamental parameters that need particular emphasis for the prevention, mitigation and control.

2.
Toxicol Rep ; 4: 358-363, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28959660

RESUMO

In this paper, we developed a mathematical model to describethe dynamics of Aflatoxins in plants, animals, and humans. Fourequilibrium points were found, and their stability analyses wereconducted using threshold quantities. If both are less than one, thestandardized toxic limit is not exceeded, while if both are greater thanone it is exceeded in both animals and humans. Standardized toxic limitis exceeded in a relevant host (animals or humans) when their respectivethreshold quantity is greater than one. Numerical simulations werecarried out to support the analytic results. The need to use experimentaldata in the model is also shown. This could ease satisfactoryharmonization of acceptable standards and facilitate international tradeof food and feeds.

3.
Comput Math Methods Med ; 2017: 3573082, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29312460

RESUMO

This paper aims to study the dynamics of immune suppressors/checkpoints, immune system, and BCG in the treatment of superficial bladder cancer. Programmed cell death protein-1 (PD-1), cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), and transforming growth factor-beta (TGF-ß) are some of the examples of immune suppressors/checkpoints. They are responsible for deactivating the immune system and enhancing immunological tolerance. Moreover, they categorically downregulate and suppress the immune system by preventing and blocking the activation of T-cells, which in turn decreases autoimmunity and enhances self-tolerance. In cancer immunotherapy, the immune checkpoints/suppressors prevent and block the immune cells from attacking, spreading, and killing the cancer cells, which leads to cancer growth and development. We formulate a mathematical model that studies three possible dynamics of the treatment and establish the effects of the immune checkpoints on the immune system and the treatment at large. Although the effect cannot be seen explicitly in the analysis of the model, we show it by numerical simulations.


Assuntos
Antineoplásicos/farmacologia , Vacina BCG/uso terapêutico , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Imunoterapia/métodos , Neoplasias da Bexiga Urinária/tratamento farmacológico , Neoplasias da Bexiga Urinária/imunologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Sistema Imunitário/efeitos dos fármacos , Sistema Imunitário/patologia , Modelos Biológicos , Neoplasias da Bexiga Urinária/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...